ArticleThe EMBO journal2026
Differential roles for the spindle assembly checkpoint in error surveillance and mitotic timing.
Article in The EMBO journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Spindle assembly checkpoint (SAC) components have been proposed to act as both a surveillance mechanism monitoring mitotic fidelity and as a timer that ensures sufficient time for chromosome alignment to occur. To evaluate these roles, we utilized an SAC-deficient cell line generated by eliminating the full-length Cdc20 translational isoform (Cdc20 ∆FL), and defined genetic interactions using CRISPR/Cas9-based screening. Cdc20 ∆FL cells display synthetic-lethal relationships with genes required for chromosome segregation, highlighting the role of the SAC in error surveillance. Interestingly, we found that the SAC component Mad2, which has been proposed to act as an essential "timer" to control anaphase onset by preventing premature APC/C activation, becomes dispensable for viability in Cdc20 ∆FL cells. Our targeted analysis indicates that regulation of mitotic timing involves a combination of Mad2 inhibition of APC/C-Cdc20, Cdk1-mediated Cdc20 phosphorylation preventing premature APC/C-Cdc20 activation, and total Cdc20 protein levels. Simultaneously perturbing these pathways results in premature mitotic exit and catastrophic chromosome mis-segregation.
Identifiers
42919995What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.